Therefore, we propose a possible oncogenic mechanism involving the high expression of SUMO family members, which increases the expression levels of M6A methylation regulators and in turn increases the oncogenic effect of M6A methylation regulators in PAAD. This evidence concerns the gene METTL3 and pancreatic adenocarcinoma.